Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-15 4:01 pm Purchase |
2023-12-05 | 13G | Blink Charging Co. BLNK |
Citadel Advisors LLC | 610,671 0.900% |
610,671 (New Position) |
Filing History |
| 2023-11-20 4:37 pm Purchase |
2023-11-08 | 13G | Turtle Beach Corporation TBCH |
Citadel Advisors LLC | 906,771 5.200% |
906,771 (New Position) |
Filing History |
| 2023-11-17 5:12 pm Purchase |
2023-11-07 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 3,839,829 5.400% |
2,335,959 (+155.33%) |
Filing History |
| 2023-11-17 4:23 pm Purchase |
2023-11-07 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Citadel Advisors LLC | 2,092,488 8.300% |
2,092,488 (New Position) |
Filing History |
| 2023-11-17 4:21 pm Purchase |
2023-11-07 | 13G | Appian Corporation APPN |
Citadel Advisors LLC | 1,957,197 4.700% |
1,957,197 (New Position) |
Filing History |
| 2023-11-13 4:41 pm Purchase |
2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE |
Citadel Advisors LLC | 1,181,167 8.500% |
1,181,167 (New Position) |
Filing History |
| 2023-11-13 4:34 pm Purchase |
2023-11-03 | 13G | Korro Bio, Inc. KRRO |
Citadel Advisors LLC | 546,218 6.800% |
546,218 (New Position) |
Filing History |
| 2023-11-06 4:34 pm Purchase |
2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP |
Citadel Advisors LLC | 1,027,959 6.000% |
1,027,959 (New Position) |
Filing History |
| 2023-10-26 4:01 pm Purchase |
2023-10-16 | 13G | Groupon, Inc. GRPN |
Citadel Advisors LLC | 1,344,504 4.300% |
1,344,504 (New Position) |
Filing History |
| 2023-10-24 09:01 am Purchase |
2023-10-12 | 13D | Venator Materials PLC VNTRF |
Citadel Advisors LLC | 1 25.300% |
1 (New Position) |
Filing History |
| 2023-10-16 4:01 pm Purchase |
2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
Citadel Advisors LLC | 1,593,936 5.700% |
1,593,936 (New Position) |
Filing History |
| 2023-10-13 4:50 pm Purchase |
2023-10-03 | 13G | Allakos Inc. ALLK |
Citadel Advisors LLC | 4,766,929 5.500% |
4,766,929 (New Position) |
Filing History |
| 2023-10-02 4:13 pm Purchase |
2023-09-20 | 13G | Dutch Bros Inc. BROS |
Citadel Advisors LLC | 3,208,873 5.400% |
3,208,873 (New Position) |
Filing History |
| 2023-09-05 4:14 pm Purchase |
2023-08-25 | 13G | Aclaris Therapeutics, Inc. ACRS |
Citadel Advisors LLC | 3,586,764 5.100% |
3,586,764 (New Position) |
Filing History |
| 2023-08-31 4:01 pm Purchase |
2023-08-21 | 13G | Arhaus, Inc. ARHS |
Citadel Advisors LLC | 2,887,707 5.400% |
2,887,707 (New Position) |
Filing History |
| 2023-08-21 4:07 pm Purchase |
2023-08-11 | 13G | Benitec Biopharma Inc. BNTC |
Citadel Advisors LLC | 180,030 6.900% |
180,030 (New Position) |
Filing History |
| 2023-08-11 4:01 pm Purchase |
2023-08-01 | 13G | Expensify, Inc. EXFY |
Citadel Advisors LLC | 2,711,663 4.000% |
2,711,663 (New Position) |
Filing History |
| 2023-07-27 4:01 pm Purchase |
2023-07-17 | 13G | Semper Paratus Acquisition Corporation LGST |
Citadel Advisors LLC | 933,454 5.900% |
933,454 (New Position) |
Filing History |
| 2023-07-10 4:01 pm Purchase |
2023-06-29 | 13G | Janux Therapeutics, Inc. JANX |
Citadel Advisors LLC | 2,126,135 5.100% |
2,126,135 (New Position) |
Filing History |
| 2023-07-03 4:02 pm Purchase |
2023-06-23 | 13G | Nektar Therapeutics NKTR |
Citadel Advisors LLC | 9,729,752 5.100% |
9,729,752 (New Position) |
Filing History |